Native-like Env trimers as a platform for HIV-1 vaccine design

被引:195
作者
Sanders, Rogier W. [1 ,2 ]
Moore, John P. [1 ]
机构
[1] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA
[2] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands
基金
欧洲研究理事会;
关键词
Env trimers; HIV-1; vaccines; neutralizing antibodies; IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN TRIMERS; BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; B-CELL RECEPTORS; CRYSTAL-STRUCTURE; AFFINITY MATURATION; GP140; TRIMERS; RECOMBINANT GLYCOPROTEIN-120; PROTEOLYTICALLY MATURE;
D O I
10.1111/imr.12481
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe the development and potential use of various designs of recombinant HIV-1 envelope glycoprotein trimers that mimic the structure of the virion-associated spike, which is the target for neutralizing antibodies. The goal of trimer development programs is to induce broadly neutralizing antibodies with the potential to intervene against multiple circulating HIV-1 strains. Among the topics we address are the designs of various constructs; how native-like trimers can be produced and purified; the properties of such trimers in vitro and their immunogenicity in various animals; and the immunization strategies that may lead to the eventual elicitation of broadly neutralizing antibodies. In summary, native-like trimers are a now a platform for structure- and immunology-based design improvements that could eventually yield immunogens of practical value for solving the long-standing HIV-1 vaccine problem.
引用
收藏
页码:161 / 182
页数:22
相关论文
共 214 条
[1]   A New Approach to Produce HIV-1 Envelope Trimers BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS [J].
AlSalmi, Wadad ;
Mahalingam, Marthandan ;
Ananthaswamy, Neeti ;
Hamlin, Christopher ;
Flores, Dalia ;
Gao, Guofen ;
Rao, Venigalla B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (32) :19780-19795
[2]   EFFECT OF DOSE AND IMMUNIZATION SCHEDULE ON IMMUNE-RESPONSE OF BABOONS TO RECOMBINANT GLYCOPROTEIN-120 OF HIV-1 [J].
ANDERSON, KP ;
LUCAS, C ;
HANSON, CV ;
LONDE, HF ;
IZU, A ;
GREGORY, T ;
AMMANN, A ;
BERMAN, PW ;
EICHBERG, JW .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) :960-969
[3]   Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design [J].
Andrabi, Raiees ;
Voss, James E. ;
Liang, Chi-Hui ;
Briney, Bryan ;
Mccoy, Laura E. ;
Wu, Chung-Yi ;
Wong, Chi-Huey ;
Poignard, Pascal ;
Burton, Dennis R. .
IMMUNITY, 2015, 43 (05) :959-973
[4]   Accurate design of megadalton-scale two-component icosahedral protein complexes [J].
Bale, Jacob B. ;
Gonen, Shane ;
Liu, Yuxi ;
Sheffler, William ;
Ellis, Daniel ;
Thomas, Chantz ;
Cascio, Duilio ;
Yeates, Todd O. ;
Gonen, Tamir ;
King, Neil P. ;
Baker, David .
SCIENCE, 2016, 353 (6297) :389-394
[5]   Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy [J].
Bartesaghi, Alberto ;
Merk, Alan ;
Borgnia, Mario J. ;
Milne, Jacqueline L. S. ;
Subramaniam, Sriram .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (12) :1352-1357
[6]   Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 [J].
Beddows, S ;
Schülke, N ;
Kirschner, M ;
Barnes, K ;
Franti, M ;
Michael, E ;
Ketas, T ;
Sanders, RW ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8812-8827
[7]   A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120 [J].
Beddows, Simon ;
Franti, Michael ;
Dey, Antu K. ;
Kirschner, Marc ;
Iyer, Sal Prasad N. ;
Fisch, Danielle C. ;
Ketas, Thomas ;
Yuste, Eloisa ;
Desrosiers, Ronald C. ;
Klasse, Per Johan ;
Maddon, Paul J. ;
Olson, William C. ;
Moore, John P. .
VIROLOGY, 2007, 360 (02) :329-340
[8]   Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A [J].
Beddows, Simon ;
Kirschner, Marc ;
Campbell-Gardener, Lila ;
Franti, Michael ;
Dey, Antu K. ;
Iyer, Sai Prasad N. ;
Maddon, Paul J. ;
Paluch, Maciej ;
Master, Aditi ;
Overbaugh, Julie ;
VanCott, Thomas ;
Olson, William C. ;
Moore, John P. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (06) :569-579
[9]   Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein [J].
Behrens, Anna-Janina ;
Vasiljevic, Snezana ;
Pritchard, Laura K. ;
Harvey, David J. ;
Andev, Rajinder S. ;
Krumm, Stefanie A. ;
Struwe, Weston B. ;
Cupo, Albert ;
Kumar, Abhinav ;
Zitzmann, Nicole ;
Seabright, Gemma E. ;
Kramer, Holger B. ;
Spencer, Daniel I. R. ;
Royle, Louise ;
Lee, Jeong Hyun ;
Klasse, Per J. ;
Burton, Dennis R. ;
Wilson, Ian A. ;
Ward, Andrew B. ;
Sanders, Rogier W. ;
Moore, John P. ;
Doores, Katie J. ;
Crispin, Max .
CELL REPORTS, 2016, 14 (11) :2695-2706
[10]   Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies [J].
Bhiman, Jinal N. ;
Anthony, Colin ;
Doria-Rose, Nicole A. ;
Karimanzira, Owen ;
Schramm, Chaim A. ;
Khoza, Thandeka ;
Kitchin, Dale ;
Botha, Gordon ;
Gorman, Jason ;
Garrett, Nigel J. ;
Karim, Salim S. Abdool ;
Shapiro, Lawrence ;
Williamson, Carolyn ;
Kwong, Peter D. ;
Mascola, John R. ;
Morris, Lynn ;
Moore, Penny L. .
NATURE MEDICINE, 2015, 21 (11) :1332-1336